Katalog der Deutschen Nationalbibliothek

Gesamter Bestand

Musikarchiv

Exilsammlungen

Buchmuseum

Suchformular zurücksetzen

Expertensuche ?

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Dienstag 18. November 2025: Die Lesesäle der Deutschen Nationalbibliothek in Frankfurt am Main öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 18 November 2025: The reading rooms of the German National Library in Frankfurt am Main will open at 13:00 due to a staff assembly.

Mittwoch, 19. November 2025: Die Deutsche Nationalbibliothek in Leipzig ist geschlossen.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

121 - 127 von 127

	121	Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System Enthalten in BioDrugs Bd. 37, 6.3.2023, Nr. 3, date:5.2023: 397-407
	122	Similarity assessment by multivariate statistics method based on the distance between biosimilar and originator Enthalten in Bioresources and Bioprocessing Bd. 8, 29.3.2021, Nr. 1, date:12.2021: 1-7
	123	Single-cell RNA-seq data have prevalent blood contamination but can be rescued by Originator, a computational tool separating single-cell RNA-seq by genetic and contextual information Enthalten in Genome biology Bd. 26, 11.3.2025, Nr. 1, date:12.2025: 1-13
	124	Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden Enthalten in Biologics in therapy Bd. 3, 28.5.2013, Nr. 1, date:6.2013: 35-43
	125	The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review Enthalten in Advances in therapy Bd. 37, 15.10.2020, Nr. 12, date:12.2020: 4831-4847
	126	The Nocebo Effect in a Non-Medical Switching Program from Originator to Biosimilar Infliximab in Inflammatory Bowel Disease Enthalten in BioDrugs Bd. 36, 12.8.2022, Nr. 5, date:9.2022: 639-644
	127	To the Editor; A Commentary on “Switching From Originator to Biosimilar Human Growth Hormone Using a Dialogue Teamwork: Single-Center Experience From Sweden” Enthalten in Biologics in therapy Bd. 4, 23.4.2014, Nr. 1-2, date:12.2014: 69-71